genie nga showtime
Nathan Cleary has opened up on his future on the field, declaring there is a reason why winning his fourth straight NRL premiership has not dulled his motivations. But he also has his mind set on family life beyond footy after sharing his dream of becoming a parent with his Matildas superstar partner Mary Fowler. The 27-year-old is on the comeback trail from off-season shoulder surgery and facing a huge challenge to keep Penrith on top in 2025 following the departure of running mates Jarome Luai, James Fisher-Harris and Sunia Turuva. Know the news with the 7NEWS app: Download today “It’s a question that often gets asked, about motivation,” Cleary said on ex-NRL player Keegan Hipgrave’s podcast . “The way I think of it is I’m not really a person who will sit down and have yearly goals. I know what I want but it comes from little improvements each day and trying to find the joy in that. “I remember goal-setting when I was younger. All I want to do is play NRL, and then you get to NRL, it’s like alright, what’s next? Then it’s alright, if I win a competition I could happily retire. “But then you win a competition, it’s alright, well, this is pretty addictive, I want to win another one.” Cleary said his career turned in 2019-20 when he began caring less about external opinions, realising he was worried within games that he would be criticised for mistakes. His father and coach Ivan proved crucial to that turnaround. “I think in a way it’s almost disrespectful to the people in your corner if you’re so worried about what other people are thinking and not taking their opinions on board,” Cleary said. “I’ve had such a great group around me, particularly family, teammates, coaches all the way through, and I was almost neglecting that for these random people who wanted to have a shot at me.” Fowler has since become an important sounding board on the occasions the sporting stars do want to discuss their on-field pursuits. “She definitely understands,” Cleary said. “People look at us and think we’re talking about our sport all the time but sometimes it’s just nice to sit there as two human beings and enjoy other’s company and talk about something other than sport. “When we’re together we just enjoy each other’s company but it’s that support and trust that if something is going wrong we can talk to each other about it and bounce ideas off each other. It’s been really nice.” The discussion around Cleary and Fowler inevitably took over the podcast, with Hipgrave keen to explore how the Panthers halfback navigates the long-distance relationship. “Sometimes you just get home and you want a little cuddle but I think it’s helped us in a way to connect on more than just a physical level and actually have genuine conversations,” he said. “We just navigate around it and when we do see each other, it’s the best thing ever. You are really grateful for those moments we get to spend together. “Constant communication is what works for us, we make a real emphasis on that. And compromise as well. You’re not always going to love the same things. “The thing that I’ve noticed about having a partner is I just want to make her happy and I want her to feel safe and feel like I’m there for her so anything she wants to do, I’ll be like ‘yeah I’ll do that because it’s going to make you happy’.” Cleary said he walked on egg shells early when he was unsure if he could joke with Fowler as he does with family and friends. But more than a year on, they are serious enough that he was willing to share his hopes to one day have children with her. Hipgrave bounced off Cleary saying he “would love” to have kids in the future to ask if he and Fowler were thinking about it soon. “It’s obviously tough that we are both pretty stuck into our sport,” Cleary said. “I definitely want to in the future. I’d love for it to be with Mary, I just think she’d be the best mother but yeah we’ll see. “It’s not a rush at the moment but definitely in the future. I see that post-footy, I would love to have a little family of my own.” While Cleary has achieved it all in his sport, Fowler is just 21 and still coming into her own as a Manchester City star and Matildas leader. Cleary had earlier spoken of the strong relationships he has with his parents and three siblings. “I’m really lucky with my family. We’ve got such a great close-knit family,” he said. “My parents are still together and they’ve just taught us what caring and love is about. I’ve got three siblings, we’re always super close.”
MetLife Investment Management LLC increased its position in shares of Maravai LifeSciences Holdings, Inc. ( NASDAQ:MRVI – Free Report ) by 129.1% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 64,736 shares of the company’s stock after acquiring an additional 36,476 shares during the period. MetLife Investment Management LLC’s holdings in Maravai LifeSciences were worth $538,000 at the end of the most recent reporting period. Other institutional investors and hedge funds have also bought and sold shares of the company. Price T Rowe Associates Inc. MD raised its position in shares of Maravai LifeSciences by 5.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 73,595 shares of the company’s stock worth $639,000 after acquiring an additional 3,575 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Maravai LifeSciences by 310.2% in the 2nd quarter. GAMMA Investing LLC now owns 3,585 shares of the company’s stock valued at $26,000 after acquiring an additional 2,711 shares in the last quarter. Blue Trust Inc. bought a new stake in shares of Maravai LifeSciences in the 2nd quarter valued at $44,000. Bank of New York Mellon Corp lifted its position in shares of Maravai LifeSciences by 30.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 506,413 shares of the company’s stock valued at $3,626,000 after acquiring an additional 117,120 shares during the period. Finally, Liontrust Investment Partners LLP boosted its stake in Maravai LifeSciences by 14.7% during the second quarter. Liontrust Investment Partners LLP now owns 43,845 shares of the company’s stock worth $314,000 after acquiring an additional 5,628 shares in the last quarter. Institutional investors and hedge funds own 50.25% of the company’s stock. Maravai LifeSciences Trading Down 0.8 % NASDAQ MRVI opened at $5.05 on Friday. The company has a current ratio of 10.74, a quick ratio of 9.94 and a debt-to-equity ratio of 0.89. The firm has a market capitalization of $1.28 billion, a P/E ratio of -3.08 and a beta of -0.08. The business has a fifty day simple moving average of $6.74 and a 200 day simple moving average of $7.94. Maravai LifeSciences Holdings, Inc. has a 12 month low of $4.28 and a 12 month high of $11.56. Insider Activity Analyst Upgrades and Downgrades Several research firms have weighed in on MRVI. Wolfe Research initiated coverage on shares of Maravai LifeSciences in a research note on Thursday, November 14th. They issued a “peer perform” rating for the company. Robert W. Baird decreased their target price on Maravai LifeSciences from $10.00 to $9.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. William Blair reiterated a “market perform” rating on shares of Maravai LifeSciences in a report on Friday, November 8th. Morgan Stanley cut Maravai LifeSciences from an “overweight” rating to an “equal weight” rating and reduced their price objective for the company from $11.00 to $10.00 in a research note on Tuesday, August 13th. Finally, The Goldman Sachs Group lowered Maravai LifeSciences from a “neutral” rating to a “sell” rating and lowered their target price for the stock from $7.00 to $4.25 in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $10.03. View Our Latest Report on Maravai LifeSciences About Maravai LifeSciences ( Free Report ) Maravai LifeSciences Holdings, Inc, a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. Recommended Stories Want to see what other hedge funds are holding MRVI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maravai LifeSciences Holdings, Inc. ( NASDAQ:MRVI – Free Report ). Receive News & Ratings for Maravai LifeSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maravai LifeSciences and related companies with MarketBeat.com's FREE daily email newsletter .Lawrence Tech alumni have a chance to go back to school
European countries suspend Syrian asylum decisions after Assad's fall
MAPS IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages WM Technology, Inc. Investors to Secure Counsel Before Important December 16 Deadline in Securities Class Action First Filed by the Firm – MAPSThe Saints are making contingency plans to play without QB Derek Carr as they try to stay alive
‘A timely book’Eagles QB Jalen Hurts is in the NFL’s concussion protocol. His status for Sunday is uncertain
Downstream Processing Market Witnesses Rapid Growth Fueled by Biopharmaceutical Demand and Technological Advancements | Report by S&S Insider
Broncos players linked to Cowboys switch in fallout to Reece Robson's NRL move to Roosters
Arizona tourism director resigns amid conflict of interest claimsWASHINGTON (AP) — President Joe Biden said Sunday that the sudden collapse of the Syrian government under Bashar Assad is a “fundamental act of justice” after decades of repression, but it was “a moment of risk and uncertainty” for the Mideast. Speaking at the White House, Biden said the U.S. was not sure of Assad's whereabouts, but was monitoring reports he was seeking refuge in Moscow. Biden credited action by the U.S. and its allies for weakening Syria's backers — Russia, Iran and Hezbollah. He said “for the first time” that they could no longer defend Assad's grip on power. “Our approach has shifted the balance of power in the Middle East," Biden said. THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below. WASHINGTON (AP) — The sudden collapse of the Syrian government under Bashar Assad is forcing the Biden administration and the incoming Trump team to confront intensifying questions about the possibility of greater conflicts across the Middle East. President-elect Donald Trump said Sunday that Assad had fled his country, which his family had ruled for decades , because close ally Vladimir Putin, the Russian president, “was not interested in protecting him any longer.” Those comments on Trump's social media platform came a day after he used another post to decry the possibility of the U.S. intervening militarily in Syria to aid the rebels, declaring, “THIS IS NOT OUR FIGHT." The Biden administration had no intention of intervening, according to President Joe Biden's national security adviser. Biden was meeting with his national security team at the White House on Sunday. He was expected to make public comments later in the day. The U.S has about 900 troops in Syria, including forces working with Kurdish allies in the opposition-held northeast to prevent any resurgence of the Islamic State group. Assad's fall adds to an already tense situation throughout much of region on many fronts, including Israel's war with Hamas in Gaza and its fragile cease-fire with Hezbollah in Lebanon. Trump, who takes office Jan. 20, 2025, made a connection between the upheaval in Syria and Russia's war in Ukraine , noting that Assad's allies in Moscow, as well as in Iran, the main sponsor of Hamas and Hezbollah, “are in a weakened state right now.” The Syrian opposition that brought down Assad is led by Hayat Tahrir al-Sham . The Biden administration has designated the group as a terrorist organization and says it has links to al-Qaida, although Hayat Tahrir al-Sham says it has since broken ties with al-Qaida. Vice President-elect JD Vance , a veteran of the U.S.-led war in Iraq, wrote on own social media Sunday to express skepticism about the insurgents. “Many of ‘the rebels’ are a literal offshoot of ISIS. One can hope they’ve moderated. Time will tell,” he said, using another acronym for the group. Trump has suggested that Assad's ouster can advance the prospects for an end to fighting in Ukraine, which was invaded by Russia in February 2022. Trump wrote that Putin's government “lost all interest in Syria because of Ukraine” and the Republican called for an immediate cease-fire, a day after meeting in Paris with the French and Ukrainian leaders . Daniel B. Shapiro, a deputy assistant secretary of defense for the Middle East, said the American military presence will continue in eastern Syria but was “solely to ensure the enduring defeat of ISIS and has nothing to do with other aspects of this conflict.” “We call on all parties in Syria to protect civilians, particularly those from Syria’s minority communities to respect international military norms and to work to achieve a resolution to include the political settlement,” Shapiro said. “Multiple actors in this conflict have a terrible track record to include Assad’s horrific crimes, Russia’s indiscriminate aerial bomb bombardment, Iranian-back militia involvement and the atrocities of ISIS," he added. Shapiro, however, was careful not to directly say Assad had been deposed by the insurgents. “If confirmed, no one should shed any tears over the Assad regime,” he said. As they pushed toward the Syrian capital of Damascus, the opposition freed political detainees from government prisons. The family of missing U.S. journalist Austin Tice renewed calls to find him. “To everyone in Syria that hears this, please remind people that we’re waiting for Austin,” Tice’s mother, Debra, said in comments that hostage advocacy groups spread on social media. "We know that when he comes out, he’s going to be fairly dazed & he’s going to need lots of care & direction. Direct him to his family please!” Tice disappeared in 2012 outside Damascus, amid intensification of what became a civil war stretching more than a decade. ___ Associated Press writer Jon Gambrell in Manama, Bahrain, contributed to this report. Will Weissert, The Associated PressThere are lots of reasons some people who want to get into the stock market never actually start buying shares. One is a lack of funds. But in reality it is possible to invest with just a few hundred pounds (or even less). Another is a lack of knowledge. But, although experience can help, the way I am buying shares now is the same way I would if I had my first stock market moment all over again. How I invest £500 When I have £500 to invest, what I do with it depends on how much else I may already have invested. That is because an important risk management principle is diversifying across different shares in case one (or more!) is disappointing. So, as I already have a portfolio of different shares, I am happy to put £500 into a single share. But I do not – ever – put all of my money into one company. If £500 was all I had, therefore, I would spread it over different shares. I want to invest efficiently, so I use a . In some situations, I use a or may consider using a . What I am looking for Before I start buying shares, I want to make sure I know as well as I can what I am getting into. So I stick to areas I think I understand, meaning I am better able to assess a company’s position and prospects. If I do not understand an area, I can always take time to do some research and improve my knowledge of it before investing. Next, I look for companies I think have a competitive advantage and a target market I expect to remain sizeable over time. One mistake new and experienced investors alike can make is not paying enough attention to a company’s accounts. If it has lots of debt on the balance sheet, that can make it unattractive. Profitable companies have gone bankrupt before now simply because they cannot repay their debt. I also look at . A good business can make for a poor investment if I overpay for its shares. Putting my money where my mouth is One share I think exemplifies my approach is my holding in asset manager ( ). The market for asset management is large and I expect that it will remain that way for the long term (which is my , by the way). With a strong brand, long asset management experience, and millions of customers in multiple markets, I see M&G as having competitive advantages. It aims to maintain or raise its dividend per share each year (although in practice that is never a sure thing). With a 10% dividend yield, the share is a lucrative source of for me. Will that last? One risk I see is that customers pulling more funds out than they put in could hurt profits. In M&G’s non-Heritage business, that happened in the first half of the year. I will be keeping an eye on that risk, as I do like the !
Coleen Rooney set to become new Holly Willoughby as she’s poised to sign big money ITV deal cashing in on I’m a CelebRepresentative image HYDERABAD: Axis Bank officials from Begumpet branch in Hyderabad are accused of allegedly siphoning off Rs 6.5 crore from account of a man of Indian origin living in New South Wales, Australia. Police said the cash was allegedly siphoned off over past two years from the premium account of Paritosh Upadhyay, an overseas citizen of India (OCI). The accused include former branch head Sridevi Raghu, senior partner Venkataramana Pasarla, service partner Surekha Saini, senior vice-president Hari Vijay and others. They have been charged with cheating by impersonation , cheating by fraudulent means, criminal breach of trust by a banker, forgery and forgery by electronic means. Upadhyay said bank officials forged his signatures to siphon off the cash and said he waited for two years for a solution after reporting the crime to the bank management, but there was no action. The accused used the loose-leaf cheques to withdraw amounts from his account and also transferred the money without any written instructions. Stay updated with the latest news on Times of India . Don't miss daily games like Crossword , Sudoku , and Mini Crossword .